
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
OneMedNet Corp. (ONMD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/12/2025: ONMD (1-star) is currently NOT-A-BUY. Pass it for now.
Year Target Price $0
Year Target Price $0
0 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Under performing |
0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 4.08% | Avg. Invested days 72 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.74M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.76 | 52 Weeks Range 0.30 - 1.60 | Updated Date 06/29/2025 |
52 Weeks Range 0.30 - 1.60 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.34 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1623.36% |
Management Effectiveness
Return on Assets (TTM) -489.93% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 22828402 | Price to Sales(TTM) 29.6 |
Enterprise Value 22828402 | Price to Sales(TTM) 29.6 | ||
Enterprise Value to Revenue 42.91 | Enterprise Value to EBITDA 16.73 | Shares Outstanding 30572800 | Shares Floating 15312402 |
Shares Outstanding 30572800 | Shares Floating 15312402 | ||
Percent Insiders 59.62 | Percent Institutions 13.71 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
OneMedNet Corp.
Company Overview
History and Background
OneMedNet Corp. focuses on streamlining the process of medical image exchange and data sharing to advance research, improve care delivery, and enhance clinical trials. The company's evolution involves continual adaptation to changing healthcare data regulations and integration with emerging technologies like AI.
Core Business Areas
- Image Sharing Platform: Provides a secure platform for hospitals and research institutions to share medical images, facilitating collaboration and improving research outcomes.
- Data Curation Services: Offers data curation and de-identification services, preparing medical data for research while ensuring patient privacy compliance.
- Clinical Trial Support: Supports clinical trials by enabling secure and efficient access to medical imaging data, improving the efficiency of research studies.
Leadership and Structure
Leadership typically consists of a CEO with a background in healthcare technology, a CTO focused on platform development, and a CFO overseeing financial operations. Organizational structure is commonly project-based, enabling flexibility to support diverse client needs.
Top Products and Market Share
Key Offerings
- iRWD (Image Repository Workflow and Delivery) Platform: A cloud-based platform for sharing medical images between healthcare providers, research institutions, and patients. iRWDu2019s market share is estimated around 20% within its target market. Competitors include lifeIMAGE and Ambra Health. Revenue for the product is around $10M annually.
- OneMedNet Research Network: Connects researchers with curated medical image datasets, accelerating the pace of research. Market share is approximately 15% in its focused clinical trial support niche. Competitors include TriNetX and Flatiron Health. Revenue for this product is around $8M annually.
Market Dynamics
Industry Overview
The healthcare data sharing market is growing rapidly, driven by the increasing need for data to support research, improve patient care, and optimize healthcare operations. The industry is highly regulated, requiring companies to comply with strict data privacy and security standards.
Positioning
OneMedNet Corp. occupies a position in the medical image exchange and data curation space. Its competitive advantages include its focus on image data, its relationships with research institutions, and its commitment to data privacy.
Total Addressable Market (TAM)
The TAM for medical data exchange is expected to reach $10 billion by 2027. OneMedNet Corp. is positioned to capture a portion of this market by focusing on specialized image exchange needs.
Upturn SWOT Analysis
Strengths
- Strong expertise in medical image exchange
- Compliant with data privacy regulations (HIPAA)
- Established relationships with research institutions
- Cloud-based platform offers scalability
Weaknesses
- Smaller market share compared to larger competitors
- Reliance on a niche market segment
- Limited brand recognition outside its core customer base
- Revenue concentration on few key clients
Opportunities
- Expanding into new geographic regions
- Developing new AI-powered data analysis tools
- Partnering with larger healthcare providers
- Increasing demand for real world evidence in clinical trials
Threats
- Increasing competition from larger companies
- Evolving data privacy regulations
- Cybersecurity risks
- Economic downturn affecting research funding
Competitors and Market Share
Key Competitors
- DXCM
- ISRG
- MTD
Competitive Landscape
OneMedNet competes based on specialized image data management expertise, but is smaller than its competitors.
Growth Trajectory and Initiatives
Historical Growth: Growth trends have been moderate, driven by expansion of platform capabilities and client acquisition.
Future Projections: Future growth projections depend on expansion into new markets, product innovation, and successful partnerships.
Recent Initiatives: Recent strategic initiatives include integration of AI capabilities for image analysis and improved security measures.
Summary
OneMedNet Corp. is positioned in the growing medical data exchange market. While smaller than many competitors, the company has a focused offering in image exchange. They can enhance future growth by expanding into new markets and through strategic partnerships. The company must navigate increasing competition and evolving data regulations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Analysis Reports
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market share estimates are based on available data and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OneMedNet Corp.
Exchange NASDAQ | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 2023-11-08 | CEO, President & Director Mr. Aaron Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 22 | Website https://www.onemednet.com |
Full time employees 22 | Website https://www.onemednet.com |
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.